Skip to content

Intravenous Lidocaine for Effective Pain Relief after Orthognathic Surgery : A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Intravenous Lidocaine for Effective Pain Relief after Orthognathic Surgery : A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001574
Enrollment
56
Registered
2015-07-21
Start date
2015-07-21
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients in the control group received an intravenous normal saline bolus, then continuous infusion of normal saline, and those in the lidocaine group received an intravenous bolus of 1.5 mg/kg

Sponsors

Chung-Ang Univerisity Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who will get double jaw surgery in Chung-Ang University Hospital

Exclusion criteria

Exclusion criteria: Patients who aged 65 years , weighed 100 kg, > 3 in American society Anesthesiologist grade, had severe underlying cardio - vascular (especially atrioventricular block), renal or hepatic disease and hyperteneion, arteriosclerosis, heart failure, hyperthyroidism,DM and were allergic to local anaesthetics were excluded. Patients were also excluded if they had received opioids or non-steroidal anti-inflammatory drugs within the previous 1 week or were taking these drugs chronically as pain treatment.

Design outcomes

Primary

MeasureTime frame
Visual analogue scale pain score

Secondary

MeasureTime frame
The frequency and quantity of analgesics;The time it takes to first request pain medication;nausea, vomitting;the time to first fart ;the time to ingesting a food;toxic effect of lidocaine; the length of hospital stay

Countries

Korea, Republic of

Contacts

Public ContactUilyong Lee

Chung-Ang Univerisity Hospital

davidjoy76@gmail.com

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026